标题 |
Biomarker analysis of a randomized, placebo-controlled, double-blind, multicenter phase II trial of intravenous RO5137382/GC33 at 1600 mg Q2W in previously treated patients with unresectable advanced or metastatic hepatocellular carcinoma (HCC) (NCT01507168)
|
网址 | |
DOI | |
其它 |
期刊:Journal of Clinical Oncology 作者:Óscar Puig; Ya‐Chi Chen; Eliezer Shochat; Christine Rossin; Olga Rutman; et al 出版日期:2014-05-20 |
求助人 | |
下载 |